Recurrent Childhood Glioblastoma: Clinical Trials

8 trials for Recurrent Childhood Glioblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated, 1 withdrawn. 5 Phase 1, 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Terminated 2
Not applicable2Terminated 1, Withdrawn 1
Phase 22Completed 2

Follow Recurrent Childhood Glioblastoma: new trials by email Literature Review of Recurrent Childhood Glioblastoma trials Research Report on Recurrent Childhood Glioblastoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Pharmacological Study, Selinexor - Malignant Glioma, Recurrent Brain Neoplasm
Phase 1CompletedChildren's Oncology Group592015-10-302025-01-14
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
Laboratory Biomarker Analysis, Sargramostim, Wild-type Reovirus - Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor
Phase 1CompletedMayo Clinic62015-06-212023-04-24
Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
palbociclib isethionate, pharmacological study, laboratory biomarker analysis - Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma
Phase 1TerminatedPediatric Brain Tumor Consortium352014-12-082021-03-02
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
18F-fluoro-dihydroxyphenylalanine, Positron emission tomography (PET), Computed tomography (CT) - Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma
Not applicableTerminatedErik Mittra22014-12-012017-03-20
Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
oncolytic HSV-1716, dexamethasone, therapeutic conventional surgery - Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma
Phase 1TerminatedPediatric Brain Tumor Consortium22013-12-012016-05-30
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
gallium Ga 68-edotreotide, positron emission tomography, computed tomography - Acoustic Schwannoma, Adult Anaplastic Astrocytoma
Not applicableWithdrawnSue O'Dorisio2013-09-012017-04-28
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
cilengitide, laboratory biomarker analysis, pharmacological study - Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma
Phase 2CompletedNational Cancer Institute (NCI)302008-06-012018-08-01
Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
lapatinib ditosylate, therapeutic conventional surgery, laboratory biomarker analysis - Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Brain Stem Glioma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)522004-10-012014-05-23

Narrower conditions

Astrocytoma (8)  ·  Oligodendroglioma (7)  ·  Glioblastoma (5)  ·  Brain Neoplasms (4)  ·  Glioma (4)  ·  Medulloblastoma (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Optic Nerve Glioma (3)  ·  Choroid Plexus Neoplasms (2)  ·  Ependymoma (2)  ·  Familial ependymoma (2)  ·  Gliosarcoma (2)  ·  Neuroectodermal Tumors, Primitive (2)  ·  Central Nervous System Neoplasms (1)  ·  Craniopharyngioma (1)

Broader conditions

Neoplasms (8)  ·  Neoplasms by Histologic Type (8)  ·  Neoplasms, Germ Cell and Embryonal (8)  ·  Neoplasms, Glandular and Epithelial (8)  ·  Neoplasms, Nerve Tissue (8)  ·  Neuroectodermal Tumors (8)  ·  Neoplasms by Site (6)  ·  Nervous System Diseases (6)  ·  Nervous System Neoplasms (6)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Central Nervous System Neoplasms (4)  ·  Glioma (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Cranial Nerve Diseases (3)

Interventions

2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Calcium Dobesilate (1)  ·  Cilengitide (1)  ·  Colony-Stimulating Factors (1)  ·  Dexamethasone (1)  ·  Lapatinib (1)  ·  N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine (1)  ·  fluorodopa F 18 (1)  ·  gallium Ga 68 dotatate (1)  ·  palbociclib (1)  ·  reolysin (1)  ·  sargramostim (1)  ·  selinexor (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Pediatric Brain Tumor Consortium (2)  ·  Children's Oncology Group (1)  ·  Erik Mittra (1)  ·  Mayo Clinic (1)  ·  Sue O'Dorisio (1)

Countries

United States (8)  ·  Canada (1)

Top investigators

David Van Mater, MD (1)  ·  Erik Mittra, MD, PhD (1)  ·  Julia Glade-Bender (1)  ·  M. Sue O'Dorisio, MD, PhD (1)  ·  Mariko DeWire (1)  ·  Maryam Fouladi (1)  ·  Richard Bram (1)  ·  Tobey MacDonald (1)

Results publications

PMID 37553297, PMID 39998852

NIH funding

U01CA081457 (3), P30CA015083 (1), P30CA086862 (1), P30CA124435 (1), U10CA098543 (1), UM1CA097452 (1)